Jill Feldman/henryford.com
Feb 28, 2025, 09:06
Jill Feldman: Can we shift the narrative from ‘shared decision-making’ to ‘informed decision-making’?
Jill Feldman, Co-Founder of EGFR Resisters and Lung Cancer Patient and Advocate, shared a post on X:
“Can we shift the narrative from ‘shared decision-making’ to ‘informed decision-making’ so that the focus is where it should be – on patients/families being fully informed?
Patients and families need all the information about treatment options to understand, ask the right questions, weigh their options, and make treatment decisions based on their preferences and what matters to them/their families.
Just a thought.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 10:44
Jun 26, 2025, 10:37
Jun 26, 2025, 09:53